The Safety and Efficacy of Phage Therapy for Superficial Bacterial Infections: A Systematic Review.

Steele, Angharad Stacey, Helen J De Soir, Steven [UCL] Jones, Joshua D

Superficial bacterial infections, such as dermatological, burn wound and chronic wound/ulcer infections, place great human and financial burdens on health systems globally and are often complicated by antibiotic resistance. Bacteriophage (phage) therapy is a promising alternative antimicrobial strategy with a 100-year history of successful application. Here, we report a systematic review of the safety and efficacy of phage therapy for the treatment of superficial bacterial infections. Three electronic databases were systematically searched for articles that reported primary data about human phage therapy for dermatological, burn wound or chronic wound/ulcer infections secondary to commonly causative bacteria. Two authors independently assessed study eligibility and performed data extraction. Of the 27 eligible reports, eight contained data on burn wound infection ( = 156), 12 on chronic wound/ulcer infection ( = 327) and 10 on dermatological infections ( = 1096). Cautionary pooled efficacy estimates from the studies that clearly reported efficacy data showed clinical resolution or improvement in 77.5% ( = 111) of burn wound infections, 86.1% ( = 310) of chronic wound/ulcer infections and 94.14% ( = 734) of dermatological infections. Over half of the reports that commented on safety ( = 8/15), all published in or after 2002, did not express safety concerns. Seven early reports (1929-1987), described adverse effects consistent with the administration of raw phage lysate and co-administered bacterial debris or broth. This review strongly suggests that the use of purified phage to treat superficial bacterial infections can be highly effective and, by various routes of administration, is safe and without adverse effects.